Compare FTEC · ATEC · QFN · DRUG · MVB
FTEC, ATEC, QFN, DRUG and MVB hold at least 199 companies between them. None is in every one of them, and QFN and MVB are the most alike: 71.5% of each is the same companies.
We can see through 99.2% of these funds to individual companies. The rest is cash, bonds, or a fund whose holdings we cannot see, so every figure here is a floor.
Return, last year
Price only, last year, each fund starting at 100. No fund here paid a distribution in this window.
Side by side
| FTEC | ATEC | QFN | DRUG | MVB | |
|---|---|---|---|---|---|
| Fund | Global X | BetaShares | BetaShares | BetaShares | VanEck |
| Asset class | Sector & thematic | Sector & thematic | Sector & thematic | Sector & thematic | Sector & thematic |
| Fee a year | 0.69% | 0.48% | 0.34% | 0.57% | 0.28% |
| Fund size | $4.3m | $613.6m | $80.0m | $163.0m | $279.0m |
| Holdings | 76 | 44 | 29 | 66 | 8 |
| 1Y price return | -- | +0.1%only priced since 2026-09-24 | −4.8% | +6.5% | −4.9% |
| Distribution yield | Not yet | 1.96% | 2.18% | 3.94% | 4.45% |
| Look-through coverage | 98.3% | 99.7% | 98.5% | 99.7% | 100.0% |
Holdings, fund by fund
- Financials
- Health Care
- Information Technology
- Industrials
- Communication Services
- Everything else
- Bonds
- Cash
- CBACOMMONWEALTH BANK OF AUSTRALIA.In 2 of 5FTECnot heldATECnot heldQFN28.7%DRUGnot heldMVB19.2%
- ANZANZ GROUP HOLDINGS LIMITEDIn 2 of 5FTECnot heldATECnot heldQFN13.3%DRUGnot heldMVB20.7%
- NABNATIONAL AUSTRALIA BANK LIMITEDIn 2 of 5FTECnot heldATECnot heldQFN14.0%DRUGnot heldMVB20.2%
- WBCWESTPAC BANKING CORPORATIONIn 2 of 5FTECnot heldATECnot heldQFN13.7%DRUGnot heldMVB20.2%
- MQGMACQUARIE GROUP LIMITEDIn 2 of 5FTECnot heldATECnot heldQFN10.2%DRUGnot heldMVB17.5%
- CPUCOMPUTERSHARE LIMITED.In 1 of 5FTECnot heldATEC10.5%QFNnot heldDRUGnot heldMVBnot held
- LLYELI LILLY & COIn 1 of 5FTECnot heldATECnot heldQFNnot heldDRUG8.3%MVBnot held
- XROXERO LIMITEDIn 2 of 5FTEC1.1%ATEC8.2%QFNnot heldDRUGnot heldMVBnot held
- JNJJOHNSON & JOHNSONIn 1 of 5FTECnot heldATECnot heldQFNnot heldDRUG8.1%MVBnot held
- PMEPRO MEDICUS LIMITEDIn 1 of 5FTECnot heldATEC8.0%QFNnot heldDRUGnot heldMVBnot held
What each fund is in
Each figure is the company's weight inside that fund, so the funds are read against each other and nothing is added up. A company listed on two exchanges counts once in a fund. Each bar in the mix is one fund as 100% of itself. The striped colours are money we cannot see inside a company (cash, bonds, a fund we cannot open). Cash, bonds and funds we cannot open that come to under 1% of a bar are in Everything else.
What FTEC already gives you
- FTEC and ATEC share 1 company1.1%A floor, not a measurement: one of these funds is not fully resolved to individual companies.
- FTEC and DRUG share 0 companies0.0%A floor, not a measurement: one of these funds is not fully resolved to individual companies.
- FTEC and MVB share 0 companies0.0%A floor, not a measurement: one of these funds is not fully resolved to individual companies.
- FTEC and QFN share 0 companies0.0%A floor, not a measurement: one of these funds is not fully resolved to individual companies.
- QFN and MVB share 7 companies71.5%A floor, not a measurement: one of these funds is not fully resolved to individual companies.
- ATEC and DRUG share 0 companies0.0%
Show the other 4
- ATEC and MVB share 0 companies0.0%
- ATEC and QFN share 0 companies0.0%A floor, not a measurement: one of these funds is not fully resolved to individual companies.
- DRUG and MVB share 0 companies0.0%
- QFN and DRUG share 0 companies0.0%A floor, not a measurement: one of these funds is not fully resolved to individual companies.
Overlap is the smaller weight in every company both funds hold: the share of each fund the other already covers. Grouped by company, so a listing on two exchanges is one holding.
What each fund changed
Reading the holdings history…
Holdings are published monthly, so this is the last publication, not this week. A re-weight counts once it moves 0.25 points of the fund or more — below that, weights are just prices moving.